We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+1.52%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$486B
AUM Growth
+$2.12B
Cap. Flow
+$867M
Cap. Flow %
0.18%
Top 10 Hldgs %
13.96%
Holding
2,615
New
76
Increased
1,051
Reduced
777
Closed
79

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$3.76B
2
CI icon
Cigna
CI
+$1.44B
3
BMY icon
Bristol-Myers Squibb
BMY
+$1.26B
4
OXY icon
Occidental Petroleum
OXY
+$763M
5
DHR icon
Danaher
DHR
+$762M

Sector Composition

Rank Sector Weight
1 Healthcare 22.87%
2 Financials 13.64%
3 Consumer Discretionary 13.54%
4 Industrials 10.67%
5 Technology 10.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SSYS icon
601
Stratasys
SSYS
$779M
$99.4M 0.02%
2,847,000
+164,114
+6% +$6.88M
TWTR
602
DELISTED
Twitter, Inc.
TWTR
$99M 0.02%
2,734,063
-22,248,972
-89% -$909M
KEX icon
603
Kirby Corp
KEX
$7.26B
$98.6M 0.02%
1,285,847
+28,965
+2% +$2.3M
JJSF icon
604
J&J Snack Foods
JJSF
$1.7B
$98.4M 0.02%
889,498
+197,634
+29% +$21.4M
HPQ icon
605
HP
HPQ
$28.6B
$98M 0.02%
7,191,327
+244,015
+4% +$3.62M
ATRI
606
DELISTED
Atrion Corp
ATRI
$97.5M 0.02%
248,562
+865
+0.3% +$309K
APH icon
607
Amphenol
APH
$204B
$97.4M 0.02%
6,722,724
-401,180
-6% -$5.76M
MNK
608
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$97.1M 0.02%
825,196
-41,600
-5% -$5.13M
PDCE
609
DELISTED
PDC Energy, Inc.
PDCE
$96.9M 0.02%
1,805,918
-132,126
-7% -$7.46M
FRAN
610
DELISTED
Francesca's Holdings Corporation
FRAN
$96.5M 0.02%
597,006
+33,351
+6% +$6.43M
IONS icon
611
Ionis Pharmaceuticals
IONS
$9.28B
$94.9M 0.02%
1,649,805
+160,547
+11% +$10.2M
LABL
612
DELISTED
Multi-Color Corp
LABL
$94.2M 0.02%
1,474,746
+7,750
+0.5% +$496K
PE
613
DELISTED
PARSLEY ENERGY INC
PE
$94.1M 0.02%
5,402,841
+535,320
+11% +$9.3M
HLIO icon
614
Helios Technologies
HLIO
$2.67B
$94M 0.02%
2,467,410
-27,690
-1% -$1.07M
BECN
615
DELISTED
Beacon Roofing Supply, Inc.
BECN
$93.7M 0.02%
2,820,310
-79,760
-3% -$2.51M
PMCS
616
DELISTED
P M C SIERRA INC
PMCS
$93.3M 0.02%
10,899,390
-276,830
-2% -$2.47M
EAT icon
617
Brinker International
EAT
$10.2B
$93M 0.02%
1,613,364
+46,900
+3% +$2.68M
ALGN icon
618
Align Technology
ALGN
$12.5B
$92.9M 0.02%
1,481,689
-161,962
-10% -$9.57M
VMI icon
619
Valmont Industries
VMI
$9.5B
$92.9M 0.02%
781,664
-63,880
-8% -$7.88M
YUM icon
620
Yum! Brands
YUM
$41.2B
$92.4M 0.02%
1,427,464
-349,423
-20% -$22.1M
THC icon
621
Tenet Healthcare
THC
$21.5B
$92.4M 0.02%
1,596,069
-490,381
-24% -$25M
GK
622
DELISTED
G&K Services Inc
GK
$92.4M 0.02%
1,335,850
-72,990
-5% -$5.16M
LMT icon
623
Lockheed Martin
LMT
$138B
$92.1M 0.02%
495,194
+16,395
+3% +$3.16M
FNSR
624
DELISTED
Finisar Corp
FNSR
$91.7M 0.02%
5,133,595
+809,778
+19% +$17.2M
POOL icon
625
Pool Corp
POOL
$7.29B
$91.2M 0.02%
1,299,469
+28,640
+2% +$1.95M

Similar funds

T. Rowe Price Associates's Q2 2015 Portfolio in Review

As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

  • T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
  • T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
  • T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
  • T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
  • T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
  • T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
  • T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.

Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.